| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 08/19/2009 | EP1351677A4 Method for treating cancer |
| 08/19/2009 | EP1348706B1 Substituted thiazole derivatives bearing 3-pyridyl groups, process for preparing the same and use thereof |
| 08/19/2009 | EP1343509B1 Combination of an estrogen and an androgen for treating hormonal deficiencies in women undergoing estrogen replacement therapy |
| 08/19/2009 | EP1280566B1 Growth factor modified protein matrices for tissue engineering |
| 08/19/2009 | EP1255829B1 Inhibitor of hepatocyte growth factor activator for use in modulation of angiogenesis and cardiovascularization |
| 08/19/2009 | EP1183240B1 Beta2-adrenoceptor agonists |
| 08/19/2009 | EP1078003B1 Plasmin inhibitors from the australian brown snake, pseudonaja textilis textilis |
| 08/19/2009 | EP0971740B1 Fibronectin binding protein derived peptides which do not bind to fibronectin, antibodies thereto, and therapeutic uses |
| 08/19/2009 | CN101511793A Antitumor agent for undifferentiated gastric cancer |
| 08/19/2009 | CN101511392A Nanogel contrast agents for optical molecular imaging |
| 08/19/2009 | CN101511376A Cardiovascular preparation |
| 08/19/2009 | CN101511350A Dioxo-alkanes and dioxo-alkenes |
| 08/19/2009 | CN101508689A Synthesis of oroxylin |
| 08/19/2009 | CN101507795A Traditional Chinese medicine composite capable of preventing and treating chronic fatigue and preparation method thereof |
| 08/19/2009 | CN101507761A Traditional Chinese medicine composite for treating horse chronic hydrocephalus |
| 08/19/2009 | CN101507735A Oyster calcining technological process |
| 08/19/2009 | CN101507728A Composite for preventing and treating body acidification of diabetic |
| 08/19/2009 | CN100529759C Methods of screening apoptosis modulating compounds, compounds identified by said methods and use of said compounds as therapeutic agents |
| 08/19/2009 | CN100528898C High purity ulinastatin and its prepn process and medicine composition |
| 08/19/2009 | CN100528850C Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation |
| 08/19/2009 | CN100528834C Pharmaceutical compounds |
| 08/19/2009 | CN100528235C Conjugates of erythropoietin |
| 08/19/2009 | CN100528223C Skin collagen production promoter |
| 08/19/2009 | CN100528169C Antiinflammatory agent, agent for preventing/ameliorating allergic diseases and functional food |
| 08/19/2009 | CN100528164C Statin therapy for enhancing cognitive maintenance |
| 08/19/2009 | CN100528161C Medicinal composition |
| 08/19/2009 | CN100528159C Nicotinic receptor agonists for treatment of inflammatory diseases |
| 08/19/2009 | CN100528157C Form of presentation for 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1h-benzimidazol-5-carbonyl)-pyridin-2-yl-amino] propionic acid ethyl ester to be administered oral |
| 08/19/2009 | CN100528156C Prevention of addiction in pain management |
| 08/19/2009 | CN100528154C Malonyl-COA decarboxylase inhibitors useful as metabolic modulators |
| 08/19/2009 | CN100528149C A composition for treating neurocerebrovascular disorders |
| 08/18/2009 | US7576204 (8E,12E,14E)-21-benzoyloxy-3,6-dihydroxy-6,10,12,16,20-pentamethyl-7-((4-methylpiperazin-1-yl)carbonyl)oxy-18,19-epoxytricosa-8,12,14-trien-11-olide; inhibits angiogenesis and inhibits the production of VEGF particularly under hypoxic conditions, which makes it useful as a remedy for solid cancer |
| 08/18/2009 | US7576200 Diphenylazetidinones, process for their preparation, medicaments comprising these compounds and their use |
| 08/18/2009 | US7576198 A hydroxy compound containing substituted orpyridine, pyrazine, pyrimidine, oxazole, thiadiazole, quinoline, isoquinoline etc. as anti HIV agent, for treating AIDS |
| 08/18/2009 | US7576129 Carboxylic acid compounds |
| 08/18/2009 | US7576125 Piperonyl alcohol; storage stability |
| 08/18/2009 | US7576117 Cyclic amine CCR3 antagonist |
| 08/18/2009 | US7576114 6-(4-Bromo-2-chloro-phenylamino)-3H-benzoimidazole-5-carboxylic acid (2-hydroxy-ethoxy)-amide; anticarcinogenic, antiproliferative, and antiinflammatory agents; mitogen-activated protein kinase inhibitors |
| 08/18/2009 | US7576111 Substituted oxazolidinones and their use in the field of blood coagulation |
| 08/18/2009 | US7576104 4-(Aminomethyl)-2-(2,6-dioxo(3-piperidyl))isoindoline-1,3-dione hydrochloride; cytokines level reduced; tumor necrosis factor inhibitors; nontoxic; anticarcinogenic agents; antitumor agents (solid/blood-borne); cardiovascular disorders; osteoporosis; antiinflammatory agents; autoimmune diseases |
| 08/18/2009 | US7576100 Muscarinic agonists |
| 08/18/2009 | US7576079 Viral polymerase inhibitors |
| 08/18/2009 | US7576078 Tetrahydroquinoline analogues as muscarinic agonists |
| 08/18/2009 | US7576070 for inhibiting galectin-3- mediated cell-cell and/or cell-matrix Interactions leading to tumor diseases; hydrolyzing enzyme A |
| 08/18/2009 | US7576067 Pulsatile release compositions and methods for enhanced intestinal oligonucleotide drug absorption |
| 08/18/2009 | US7576064 Pyrazole derivative, drug composition containing the same and production intermediate therefor |
| 08/18/2009 | US7576063 prevention or treatment of disease associated with hyperglycemia: diabetes, impaired glucose tolerance, impaired fasting glycemia, diabetic complications or obesity; e.g. 4-[(4-{3-[1-carbamoyl-1-(methyl)-ethylcarbamoyl]propyl}-2-methylphenyl)methyl]-3-( beta -D-glucopyranosyloxy)-5-isopropyl-1H-pyrazole |
| 08/18/2009 | US7576050 Glucagon-like peptides and ependins for use in treatment and prevention of diabetes and neurodegenerative conditions; neuroprotective agents; neurotrophic factors |
| 08/18/2009 | US7575752 Immunogenic polypeptide for protecting pigs against viral infection or postweaning multisystemic wasting syndrome |
| 08/18/2009 | US7575577 Devices and methods for the restoration of a spinal disc |
| 08/18/2009 | CA2577233C Pharmaceutical composition containing angiotensin ii antagonist |
| 08/18/2009 | CA2481591C Stabilized ascorbic acid derivatives |
| 08/18/2009 | CA2479216C Dipyridodiazepinones as reverse transcriptase inhibitors |
| 08/18/2009 | CA2440710C Medicine of post-traumatic stress disorder |
| 08/18/2009 | CA2429133C Novel imidazole derivatives, production method thereof and use thereof |
| 08/18/2009 | CA2412208C Use of 3-substituted oxindole derivatives as kcnq potassium channel modulators |
| 08/18/2009 | CA2400268C Pyrrolopyrimidinone derivatives, process of preparation and use |
| 08/18/2009 | CA2393568C Diarylmethylpiperazines |
| 08/18/2009 | CA2392030C Urea compounds having muscarinic receptor antagonist activity |
| 08/18/2009 | CA2392028C Carbamate derivatives having muscarinic receptor antagonist activity |
| 08/18/2009 | CA2333004C Formoterol polymorphs |
| 08/18/2009 | CA2315141C Pharmaceutical compositions comprising (e)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl]-(3r,5s)-3,5-dihydroxyhept-6-enoic acid or a pharmaceutically acceptable salt thereof |
| 08/18/2009 | CA2288215C Use of immunomodulating agents |
| 08/18/2009 | CA2174526C Pseudodipeptide product possessing an imidazole group and the therapeutic, cosmetological and agri-food applications of the said product |
| 08/18/2009 | CA2105552C Soluble ligands for cd40 |
| 08/13/2009 | WO2009099177A1 Amino imidazole derivative |
| 08/13/2009 | WO2009099172A1 Pharmaceutical product |
| 08/13/2009 | WO2009099171A1 Pharmaceutical product |
| 08/13/2009 | WO2009099163A1 Pyrrolopyrimidin derivative for use as pi3k inhibitor, and use thereof |
| 08/13/2009 | WO2009099087A1 Benzylpiperizine compound |
| 08/13/2009 | WO2009099086A1 3-substituted sulfonyl piperazine derivative |
| 08/13/2009 | WO2009099080A1 Novel phenylpyrrole derivative |
| 08/13/2009 | WO2009098901A1 3,8-diaminotetrahydroquinoline derivative |
| 08/13/2009 | WO2009098238A1 Anti-trka antibodies and derivatives thereof |
| 08/13/2009 | WO2009097774A1 The use of aryl piperazine derivatives in manufacturing medicants for treating pain |
| 08/13/2009 | WO2009032308A8 Sam-ii riboswitch and uses thereof |
| 08/13/2009 | WO2008080268A8 Derivates of substituted tartaric aicd and usage for preparating beta secretase inhibitors |
| 08/13/2009 | US20090205062 Caspase-9 deficient animals and the use thereof |
| 08/13/2009 | US20090204204 Drug/Drug Deliver Systems For The Prevention And Treatment Of Vascular Disease |
| 08/13/2009 | US20090204089 Postpartum Pad |
| 08/13/2009 | US20090203842 Macromolecular Conjugates And Processes For Preparing The Same |
| 08/13/2009 | US20090203803 N-acylated chitinous polymers and methods of use thereof |
| 08/13/2009 | US20090203789 Fast Dissolution Amino Acid Composition |
| 08/13/2009 | US20090203782 Alpha 2 Delta Ligands for Fibromyalgia and Other Disorders |
| 08/13/2009 | US20090203770 COMPOSITIONS AND METHODS FOR MODULATING APOPTOSIS IN CELLS OVER-EXPRESSING Bcl-2 FAMILY MEMBER PROTEINS |
| 08/13/2009 | US20090203767 Inhibition stat-1 |
| 08/13/2009 | US20090203751 Novel 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators |
| 08/13/2009 | US20090203743 Small molecule entry inhibitors |
| 08/13/2009 | US20090203719 Enhancing treatment of mdr cancer with adenosine a3 antagonists |
| 08/13/2009 | US20090203717 Fused heterocyclic compound |
| 08/13/2009 | US20090203710 Novel piperidine derivative |
| 08/13/2009 | US20090203691 such as N1-{3-[3,5-Di(trifluoromethyl)phenyl]-1H-5-indazolyl}-(2R)-2-amino-3,3-diphenylpropanamide, having an excellent Jun N-terminal Kinase (JNK) inhibitory action, used for treating various immunologic diseases, inflammatory diseases, and/or neurodegenerative diseases |
| 08/13/2009 | US20090203633 Pyrazole derivatives, medicinal composition containing the same, medicinal use thereof, and intermediate for production thereof |
| 08/13/2009 | US20090203615 Use of activity dependent neurotrophic factor for enhancing learning and memory: pre-and post-natal administration |
| 08/13/2009 | US20090203609 Use of IL-1 inhibitors for treating IL-1 mediated diseases |
| 08/13/2009 | US20090203608 reducing lipid accumulation in an adipocyte; finding a therapeutic agents for treating obesity, diabetes, arteriosclerosis |
| 08/13/2009 | US20090203572 Method for in Vitro Molecular Evolution of Protein Function |
| 08/13/2009 | US20090203122 Peripheral nervous system specific sodium channels, DNA encoding therefor, crystallization, x-ray diffraction, computer molecular modeling, rational drug design, drug screening, and methods of making and using thereof |
| 08/13/2009 | US20090203044 Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor |
| 08/13/2009 | US20090203036 Epitope regions of a thyrotrophin (tsh) receptor, uses thereof and antibodies thereto |